Reaction

Intercepted Medication Error reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 4,617 reports · 51 co-occurring drugs

As of the last recalculation, Intercepted Medication Error appears in 4,617 FAERS reports alongside 51 co-occurring drug terms. The strongest observed disproportionality signal is LEUPROLIDE ACETATE (PRR 86.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Leuprolide Acetate	1,131	86.7	88.0
Alteplase	244	77.3	78.6
Dornase Alfa	125	29.5	29.7
Pertuzumab	118	20.1	20.1
Ado-Trastuzumab Emtansine	33	17.8	17.8
Tocilizumab	333	14.1	14.1
Valganciclovir	55	13.3	13.3
Valganciclovir Hydrochloride	55	13.3	13.3
Ranibizumab	65	11.2	11.2
Brentuximab Vedotin	24	10.6	10.6
Omalizumab	179	9.8	9.8
Blinatumomab	21	9.1	9.1
Umeclidinium Bromide And Vilanterol Trifenatate	30	8.1	8.2
Obinutuzumab	29	8.0	8.0
Fluticasone Furoate And Vilanterol Trifenatate	62	7.9	7.9
Trastuzumab	117	7.9	7.9
Umeclidinium	13	6.6	6.6
Atezolizumab	46	5.4	5.4
Bevacizumab	141	5.3	5.3
Fluticasone Propionate And Salmeterol	47	5.1	5.1
Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	10	5.1	5.1
Romiplostim	16	4.8	4.8
Pegfilgrastim	100	4.6	4.7
Leucovorin Calcium	17	4.0	4.0
Mupirocin	12	4.0	4.0
Mirabegron	34	4.0	4.0
Mupirocin Calcium	12	3.9	3.9
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	33	3.6	3.6
Rituximab	163	3.6	3.6
Cabotegravir	6	3.4	3.4
Faricimab	6	3.3	3.3
Canagliflozin	22	3.3	3.3
Vismodegib	6	3.0	3.0
Polyethylene Glycol 3350	60	2.9	2.9
Erenumab-Aooe	32	2.6	2.6
Ocrelizumab	30	2.2	2.2
Canakinumab	5	2.1	2.1
Vemurafenib	5	1.9	1.9
Belimumab	13	1.9	1.9
Carfilzomib	11	1.8	1.8
Panitumumab	6	1.7	1.7
Denosumab	75	1.7	1.7
Pirfenidone	14	1.6	1.6
Docosanol	5	1.5	1.5
Polatuzumab Vedotin	3	1.4	1.4
Glycerin, Lidocaine	4	1.3	1.3
Cenegermin-Bkbj	3	1.1	1.1
Emicizumab	3	1.1	1.1
Evolocumab	33	0.9	0.9
Droxidopa	4	0.8	0.8
Nirmatrelvir And Ritonavir	6	0.5	0.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.